Clinical Trial Update: A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of PTR-01 in adults with recessive dystrophic epidermolysis bullosa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Recessive Dystrophic Epidermolysis Bullosa

Drugs mentioned

• PTR-01

Snippet

Sponsor: Phoenix Tissue Repair, Inc. | Conditions: Recessive Dystrophic Epidermolysis Bullosa | Phase 1, Phase 2 | Status: COMPLETED